BIRC5 and neoplasm: Furthermore, the compound inhibits tumor cells proliferation in the athymic xenograft mice model, without any apparent toxicity yet suppressing the expression of Wnt target genes associated with tumor growth, including MYC (c-myc), CCND1 (cyclin D1), and BIRC5 (survivin) [156].